Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Average Target Price of $802.18

Summary by MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty-four brokerages that are presently covering the stock, Marketbeat.com reports. Ten research analysts have rated the stock with a hold rating and fourteen have given a buy r

1 Articles

MarketBeatMarketBeat
Center

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Average Target Price of $802.18

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty-four brokerages that are presently covering the stock, Marketbeat.com reports. Ten research analysts have rated the stock with a hold rating and fourteen have given a buy r

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Wednesday, September 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tarrytown icon

Tarrytown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal